Create free account
ActiveDharwad, KarnatakaSince 2018

Karunadu Oncology Haematology Associates Private Limited

Follow

Set up in 2018 in Dharwad. It has pledged its assets against loans of up to ₹10 crore from 1 lender.

CINU85320KA2018PTC119596
Get its revenue and profit

From its annual accounts, which Entiva gets and reads for you.

Ask your favourite AI

Get a plain-English summary of this company.

7 years at a glance

Loans against its assets, and when today's people joined

20192020202120222023202420252026LOANS AGAINST ITS ASSETSTODAY'S PEOPLE, WHEN THEY JOINEDRegistered as a companyState Bank of India, up to ₹10 crore, 27 Sept 2021 to still open
Loan still openLoan paid offSomeone joined, and is still there
  • 2018Registered as a company on 18 Dec 2018.
  • 2021Its biggest loan against assets, ₹10 crore with State Bank of India, is still open.

Who runs it

This page does not list its directors yet. Open the company in Entiva to see who runs it on MCA's register today.

Who has lent to it

₹10 crorein loans backed by its assets, from 1 lender

  • State Bank of India₹10 crore

    Open, taken out 27 Sept 2021

What its filings add

Karunadu Oncology Haematology Associates files these with the registrar. Entiva fetches and reads them for you.

Get Karunadu Oncology Haematology Associates's filings

Same line of business

Registered for the same kind of business, closest in size first

Keep an eye on Karunadu Oncology Haematology Associates

  • Free

    Follow the company

    An email when it files, or its directors or loans change.

  • Free

    Follow its people

    Hear when a director joins another company.

  • Free

    Map the network

    See every company its people connect to.

  • Per order

    Read the filings

    Accounts, owners and loans, in Entiva or your AI assistant.

Create a free account

No card needed to follow.

The details on this page come from public records, including MCA's register of companies as Entiva read it on . Things may have changed since. A loan amount is the most the lender can claim against the company's assets, not what is still owed.